Quest Diagnostics Inc logo

Quest Diagnostics Inc

FRA:QDI (USA)   Ordinary Shares
€ 132.45 (+1.15%) May 20
19.40
P/B:
2.49
Market Cap:
€ 14.73B ($ 16.01B)
Enterprise V:
€ 19.22B ($ 20.89B)
Volume:
-
Avg Vol (2M):
171.00
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Quest Diagnostics Inc ( ) from 1996 to May 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Quest Diagnostics stock (FRA:QDI) PE ratio as of May 21 2024 is 19.4. More Details

Quest Diagnostics Inc (FRA:QDI) PE Ratio (TTM) Chart

To

Quest Diagnostics Inc (FRA:QDI) PE Ratio (TTM) Historical Data

Total 1242
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Quest Diagnostics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-21 19.3 2024-03-14 17.0
2024-05-20 19.3 2024-03-13 17.1
2024-05-17 19.1 2024-03-12 17.0
2024-05-16 18.8 2024-03-11 16.7
2024-05-15 18.7 2024-03-08 16.7
2024-05-14 19.0 2024-03-07 16.7
2024-05-13 18.7 2024-03-06 16.5
2024-05-10 18.6 2024-03-05 16.6
2024-05-09 18.4 2024-03-04 16.5
2024-05-08 18.5 2024-03-01 16.6
2024-05-07 18.3 2024-02-29 16.6
2024-05-06 18.6 2024-02-28 16.8
2024-05-03 18.6 2024-02-27 16.7
2024-05-02 18.7 2024-02-26 16.8
2024-04-30 18.9 2024-02-23 16.6
2024-04-29 18.2 2024-02-22 16.9
2024-04-26 18.4 2024-02-21 16.4
2024-04-25 18.6 2024-02-20 16.5
2024-04-24 18.6 2024-02-19 16.5
2024-04-23 17.8 2024-02-16 16.8
2024-04-22 17.5 2024-02-15 17.1
2024-04-19 17.1 2024-02-14 17.1
2024-04-18 17.3 2024-02-13 17.3
2024-04-17 17.4 2024-02-12 16.9
2024-04-16 17.6 2024-02-09 16.9
2024-04-15 17.7 2024-02-08 17.0
2024-04-12 17.6 2024-02-07 17.1
2024-04-11 17.8 2024-02-06 16.5
2024-04-10 17.8 2024-02-05 16.6
2024-04-09 17.4 2024-02-02 16.8
2024-04-08 17.5 2024-02-01 16.8
2024-04-05 17.7 2024-01-31 17.1
2024-04-04 17.8 2024-01-30 17.2
2024-04-03 17.8 2024-01-29 17.3
2024-04-02 18.2 2024-01-26 17.2
2024-03-28 17.6 2024-01-25 16.9
2024-03-27 17.1 2024-01-24 17.0
2024-03-26 17.1 2024-01-23 17.2
2024-03-25 17.2 2024-01-22 17.5
2024-03-22 17.1 2024-01-19 17.8
2024-03-21 16.8 2024-01-18 17.6
2024-03-20 17.1 2024-01-17 17.7
2024-03-19 16.9 2024-01-16 17.6
2024-03-18 16.9 2024-01-12 17.8
2024-03-15 16.8 2024-01-11 17.9

Quest Diagnostics Inc (FRA:QDI) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Quest Diagnostics Inc logo
Quest Diagnostics Inc
NAICS : 621511 SIC : 8071
ISIN : US74834L1008

Share Class Description:

FRA:QDI: Ordinary Shares
Description
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.